Business8 sources
FTC Claims Martin Shkreli Violated Pharma Industry Ban
The Federal Trade Commission and several states allege Martin Shkreli violated a lifetime ban on involvement in the pharmaceutical industry. The FTC seeks court action for his alleged repeated violations.
Articles (8)
The Hill·
FTC: 'Pharma bro' Shkreli violated lifetime industry ban, should be held in contempt
The Guardian·
FTC and seven states seek contempt ruling against Shkreli over pharma ban
Financial Times·
FTC says ‘pharma bro’ Martin Shkreli repeatedly violated industry ban
CNBC·
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
MarketWatch·
‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
Business Insider·
FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban
United Press International·
FTC asks judge to find 'Pharma Bro' Martin Shkreli in contempt
STAT·
STAT+: FTC demands Martin Shkreli divest his pharma stocks